docetaxel

You have access
A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
YUSAKU TANAKA, CHIKARA KUNISAKI, YUSUKE IZUMISAWA, HIROCHIKA MAKINO, JUN KIMURA, SHO SATO, HIROSHI MIYAMOTO, TAKASHI KOSAKA, HIDETAKA A. ONO, MASAZUMI TAKAHASHI, KEI SATO, HIROTOSHI AKIYAMA and ITARU ENDO

Anticancer Research October 2018, 38 (10) 6015-6021; DOI: https://doi.org/10.21873/anticanres.12951
You have access
Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer
KEIJI HAYATA, TOSHIYASU OJIMA, MIKIHITO NAKAMORI, MASAKI NAKAMURA, MASAHIRO KATSUDA, JUNYA KITADANI, AKIHIRO TAKEUCHI, HIROTAKA TABATA, SHINPEI MARUOKA and HIROKI YAMAUE

Anticancer Research September 2018, 38 (9) 5267-5273; DOI: https://doi.org/10.21873/anticanres.12852
You have access
Enterocolitis in Patients with Cancer Treated with Docetaxel
FRÉDÉRIC FITENI, MARIE-JUSTINE PAILLARD, EMELINE ORILLARD, LORIANE LEFEBVRE, SARAH NADJAFIZADEH, ZOHAIR SELMANI, SALIM BENHAMIDA, ANTOINE ROLAND, ANTOINE BAUMANN, ANGÉLIQUE VIENOT, NADINE HOUÉDÉ and XAVIER PIVOT

Anticancer Research April 2018, 38 (4) 2443-2446;
You have access
Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide
NAMI UEMATSU, YUXUE ZHAO, ANNA KIYOMI, BO YUAN, KENJI ONDA, SACHIKO TANAKA, KENTARO SUGIYAMA, MUNETOSHI SUGIURA, NORIO TAKAGI, AKEMI HAYAKAWA and TOSHIHIKO HIRANO

Anticancer Research April 2018, 38 (4) 2101-2108;
You have access
Effects of Neoadjuvant 5-Fluorouracil and Cisplatin Therapy in Patients with Clinical Stage II/III Esophageal Squamous Cell Carcinoma
HIROTAKA KONISHI, HITOSHI FUJIWARA, ATSUSHI SHIOZAKI, KATSUTOSHI SHODA, TOSHIYUKI KOSUGA, TAKESHI KUBOTA, KAZUMA OKAMOTO and EIGO OTSUJI

Anticancer Research February 2018, 38 (2) 1017-1023;
You have access
Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells In Vivo
MASAHIRO UEDA, TADASHI SHIMIZU, MIYUKI MABUCHI, KOTA HORIIKE, KAORI KITAE, HIROAKI HASE, YUKO UEDA, KAZUTAKE TSUJIKAWA and AKITO TANAKA

Anticancer Research January 2018, 38 (1) 211-218;
You have access
The Relationship Between Peripheral Neuropathy Induced by Docetaxel and Systemic Inflammation-based Parameters in Patients with Breast Cancer
KOSHO YAMANOUCHI, SAYAKA KUBA, CHIKA SAKIMURA, MICHI MORITA, KENGO KANETAKA, KAZUMA KOBAYASHI, MITSUHISA TAKATSUKI, NAOMI HAYASHIDA and SUSUMU EGUCHI

Anticancer Research December 2017, 37 (12) 6947-6951;
You have access
Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells
MICHELLE J. MAYER, LAURENCE H. KLOTZ and VASUNDARA VENKATESWARAN

Anticancer Research December 2017, 37 (12) 6601-6607;
You have access
Mifepristone Has Limited Activity to Enhance the In Vivo Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer
YANG YANG, XIN LI, KENZA MAMOUNI, OMER KUCUK and DAQING WU

Anticancer Research November 2017, 37 (11) 6235-6243;
You have access
Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel
JOST VON HARDENBERG, MAIKE SCHWARTZ, THORSTEN WERNER, STEFAN FUXIUS, MARKUS MÜLLER, THOMAS FRANGENHEIM, CHRISTIAN BOLENZ, CHRISTEL WEISS and ELMAR HEINRICH

Anticancer Research September 2017, 37 (9) 5117-5124;

Main menu

User menu

Search

docetaxel

Pages